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Abstract  
BACKGROUND: Osteoprotegerin (OPG) is considered to be the cytokine that plays an important 
role in the healing process. OPG regulates bone cell biology, osteoblast–osteoclast, bone-immune 
cross-talk and maintenance of bone mass. It plays an important role in the development, induction, 
and repair of bone. Orthognathic surgery as multiples segmental osteotomies has been taken as a 
model surgery to assess the changes in osteoprotegerin levels in the post-operative bone healing 
period.
 
AIM: The aim of the study was to evaluate OPG as immunological caliper of bone healing. 
MATERIAL AND METHODS: OPG was evaluated in nine patients seeking orthognathic surgery. 
Patients were examined and checked to be medically and immunologically free prior to surgery. 
Blood samples were collected immediate pre-operative as control group and for six weeks post-
operative as study group. 
RESULTS: Data were collected from nine consecutive patients. The results showed higher levels of 
OPG. it showed significant increase in the immediate post-operative value (p = 0.001) which started 
to increase gradually during the six weeks (p < 0.001).  
CONCLUSIONS: Significant higher levels of OPG during the healing period of orthognathic surgery 
suggest the its use as immunological caliper of bone healing. 
 
 
 
Introduction 
 
Osteoprotegerin (OPG) is an antiresorptive 
cytokine and an osteoblast-secreted decoy receptor; it 
is considered a key regulator of osteoclastogenesis. It 
specifically binds to osteoclast differentiation factor 
and inhibits osteoclast maturation. OPG is involved in 
bone remodelling and in its healing system since it 
regulates bone cell biology, osteoblast-osteoclast, 
immune cross-talk and maintenance of bone mass [1].  
The RANKL-RANK-OPG cytokine system is 
one of the principal mediators in the maintenance of 
bone cell function and activation of bone remodelling 
by the Basic Multicellular Unit (BMU) which carries out 
remodelling. The balance of the trimolecular control 
factor complex composed of OPG, RANKL { receptor 
activator of nuclear factor kappa beta (NFkB ligand)}, 
It is also commonly referred to as osteoprotegerin 
ligand (OPGL) or osteoclast differentiation factor 
(ODF) and RANK (receptor activator of NFkB) 
maintains physiologic bone remodeling and renewal of 
the bone matrix [2, 3].    
Osteosynthesis of the bone matrix is achieved 
by osteoblasts and coordinated with resorption of 
extracellular bone matrix performed by osteoclasts. 
The mismatch between the activities of osteoblasts 
and osteoclasts has immunopathologic implications 
associated with either a decrease or increase of bone 
mass mineral density. The OPG–RANKL complex 
counterbalances the effect of the RANK–RANKL 
complex, thus playing the most important role in bone 
homoeostasis [4, 5]. Circulating levels of OPG were 
found to be a predictor of delayed bone healing and 
non-union of bone suggesting the active relationship 
of its circulating levels to healing process. OPG was 
found to be of value as the prognostic marker of bone 
activity, wound healing activity and the therapeutic 
progress following surgery [6-8].  Orthognathic 
surgery as an elective surgery is considered the most 
convenient in the maxillofacial surgeries to study the 
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immunological effect of surgical trauma on patients 
and changes detected in OPG levels. Patients could 
be carefully chosen intact preoperatively and not 
suffering from any systemic or immunological 
diseases, as these factors will affect the preoperative 
immunological status of the patient.   
 
 
Patients and Methods 
 
The study was conducted on nine patients 
suffering from dentofacial deformity and seeking 
correction by orthodontic-orthognathic surgery. The 
patients were chosen randomly from those attending 
the outpatient clinic of Oral and Maxillofacial Surgery 
Department at Faculty of Oral and Dental Medicine 
Cairo University. Eight patients had undergone 
bimaxillary osteotomy and case number nine had 
mandibular surgery only. All patients were healthy not 
suffering from any systemic or bone diseases and the 
age range between 16-30. 
 
Each patient was subjected to the following: 
clinical diagnosis (history, clinical evaluation, 
photographs and radiographs), pre- operative 
orthodontic treatment and patient preparation before 
surgery. All patients were informed about the surgical 
procedure and the schedule of blood samples and an 
informed consent was assigned. OPG levels were 
evaluated by taking blood samples according to the 
following schedule; immediate preoperative, 
immediate post-operative, three days, one week, two 
weeks, four weeks and six weeks post-operative. A 
Serum separator tube (SST) was used to allow 
samples to clot for two hours at room temperature or 
overnight at 4°C before centrifugation for 15 minutes 
at 1000 × g. Aliquot was removed immediately and the 
samples stored at -80°C.  Human Osteoprotegerin 
(OPG) ELISA Kit (catalogue noCSB-E04692h was 
used to detect OPG levels. The assay employed the 
quantitative sandwich enzyme immunoassay 
technique with a detection range 0.312 ng/ml-20 
ng/ml. 
 
 
Statistical analysis 
Data were fed to the computer and analysed 
using IBM SPSS software package version 20.0 [9]. 
Quantitative data were described using range 
(minimum and maximum) mean, standard deviation 
and median [10]. 
 
 
Results 
 
The post-operative course was eventful 
expect; limited mouth opening was seen in the patient 
with single jaw surgery (BSSO) and managed by 
physical therapy. One case showed periodontal 
abscess in the lower right molars; it appeared one-
month post-operatively and treated in a routine 
manner. All patients experienced periods of tolerable 
pain that decreased gradually after surgery and 
remained from 3 to 4 weeks. Oedema was observed 
in all patients and resolved gradually after 1 to three 
months (Fig. 1). 
a) 
 
b)  
 
c) 
 
d) 
 
Figure 1: Fixation of case number 8. a) Maxilla and mandible wired 
together in maxillomandibular fixation. b) Stabilisation of the maxilla 
by two plates on each side, one at piriform region and one at the 
maxillary buttress. c) Proximal segment passively seated and fixed 
to the distal segment by 3 screws. d) Bone graft and rigid fixation of 
sliding genioplasty
 
 
The changes in OPG in the whole group in 
the predetermined period immediate postoperative, 
after three days, after one week, two weeks, four 
weeks and six weeks in comparison to the 
preoperative level was investigated.  
 
 
Figure 2: Comparison between the different periods according to 
OPG ng/ml 
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It was detected that there is a significant 
increase in the level of OPG immediate post-operative 
at (p = 0.001). the concentration of OPG was started 
to increase gradually and it was significant at the 
following periods (3 days post-operative, one week, 
two weeks, four weeks and six weeks post-operative) 
at p-value <0.001. The increase in OPG level in six 
weeks postoperatively was found to be significant 
regarding the immediate post-operative value p < 
0.001 (Fig. 2). 
 
 
Discussion 
 
Osteoprotegerin (OPG) has been chosen in 
this study as the new most recent calliper. It is 
sensitive to hard tissue changes and a key regulator 
of both physiologic and pathologic osteoclast 
formation that regulates bone resorption and 
remodelling. An elevated level of serum OPG was 
connected with high bone turnover and administration 
to humans has also demonstrated marked decreases 
in bone resorption. These opinions were supported by 
the findings reported from several studies. 
In the present study Osteoprotegrin (OPG) 
showed a significant increase throughout the post-
operative period in a steady way till six weeks post-
operative. This finding is concordant with Giganti MG 
et al, [11] and Lee et al, [12] as OPG showed 
significant increase immediately after fracture. The 
results of the present study are not in agreement with 
Clombini et al, [13] he investigated the role of OPG in 
humerus fracture healing at different time points 
before and after surgery and observed higher OPG, 
but it was not significant. 
OPG can be used as marker for post- 
operative complications, it is not bone-specific as 
elevated levels may be accompanied by post-
operative complications, this opinion was supported 
by several studies [14-16]. Post-operative pain could 
be attributed to the elevated level of OPG as it is 
known to be involved in a complex cytokine network 
that causes immune activation and may contribute to 
nociceptive sensitization. This was in agreement with 
the findings that showed the relation of the significant 
increase OPG and the incidence of complex regional 
pain syndrome (CRPS) [17].
 
The assessment of OPG in the current study 
was planned for a period of six weeks post-
operatively. The follow-up period of OPG was 
concordant with previous studies, [18-20] OPG was 
assessed for 12 weeks and the increase was found to 
be significant at 4 weeks post-operative and turned to 
be not significant at 8 and 12 weeks post-operative. 
For the previous finding six weeks follow-up period is 
an appropriate duration. The significant increase 
without remission in the six weeks post-operative 
period was attributed to the process of bone healing 
following the osteotomies. Bone healing begins 
immediately after fracture or osteotomy by hematoma 
formation and release of cytokines, mesenchymal 
cells and growth factor, followed by the extended 
period of bone remodelling.
 
Orthognathic surgery has been selected as a 
model surgery in this study. Patients are young, intact, 
non-traumatized and immunocompetent. Candidates 
for orthognathic surgery are considered systemically 
and immunologically free, so for the reliability of the 
results pre-operative levels of the two callipers are 
considered control. This category of surgery being an 
elective procedure, so blood loss is easily estimated, 
operative time pre-determined and the surgical trauma 
is the planned and any adverse effect will be 
attributed to the effect of surgery. Patients 
incorporated in the present study were demanding 
surgery and has no psychological hindrance like 
patients of trauma or neoplasm. Recalls for follow-up 
was accomplished easily as orthognathic patients are 
committed to the surgeon and orthodontist.
 
Significant higher levels of OPG following 
orthognathic surgery suggest the use of OPG as a 
good calliper for the assessment of bone healing and 
regeneration of hard tissue. Further investigations with 
wide scale sample and for the extended period of time 
is needed to emphasise the application of OPG as a 
pre and postoperative immunological calliper 
predicting the post-operative healing course.
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